---  
layout: startup_page  
title: "Latigo Biotherapeutics"  
id: "latigobio.com"  
permalink: "/latigobiotherapeuticslatigobio.com02142024/"  
website: "https://www.latigobio.com/"  
funding_round: "Series A"  
funding_amount: "$135M"  
investors: "Westlake Village BioPartners, 5AM Ventures, Foresite Capital, Corner Ventures"  
about: "Latigo Biotherapeutics is a clinical-stage biotechnology company developing non-opioid pain medicines. Their lead program, LTG-001, is a Nav1.8 inhibitor in Phase 1 clinical trials for acute and chronic pain. The company utilizes human genetics and advanced technologies to identify and develop novel pain therapeutics."  
markets: "Biotechnology, Pharmaceuticals, Pain Management, Biotechnology Research"  
hq: "Thousand Oaks, California, United States"  
founded_year: "2018"  
linkedin: "https://www.linkedin.com/company/latigobio/"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/latigo-biotherapeutics"  
pitchbook: ""  

date_display: "14-Feb-2024"  
date: "2024-02-14"

# SEO Optimization  
meta_title: "Latigo Biotherapeutics - Series A Funding ($135M)"  
meta_description: "Latigo Biotherapeutics, Latigo Biotherapeutics is a clinical-stage biotechnology company developing non-opioid pain medicines. Their lead program, LTG-001, is a Nav1.8 inhibi..."  
meta_keywords: "Latigo Biotherapeutics, Biotechnology, Pharmaceuticals, Pain Management, Biotechnology Research, Series A funding"  
canonical_url: "https://startup.projectstartups.com/latigobiotherapeuticslatigobio.com02142024/"  
---